Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03983096
Brief Title: Pegylated Liposomal Doxorubicin or Epirubicin in Neoadjuvant or Adjuvant Chemotherapy for Breast Cancer.

First Submitted : June 10, 2019
First Submitted that Met QC Criteria : June 10, 2019
First Posted : June 12, 2019

Last Update Submitted that Met QC Criteria : June 10, 2019
Last Update Posted : June 12, 2019